CatalinaS DVillanuevaMD

Clinical Research Director

Dr. Villanueva is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
16660 Paramount Blvd Ste 301
Paramount, CA 90723
Phone+1 562-633-5101

Fax+1 562-602-2296

Journal Articles

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
C. Buddy Creech, M.D., M.P.H., Evan Anderson, M.D., Vladimir Berthaud, M.D., M.P.H., Inci Yildirim, M.D., Ph.D., et al., for the KidCOVE Study Group*, New England of Medicine Journal, 5/26/2022
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis
Hayden FG, Belche R, Villanueva C, ADIS International LTD, 2/1/2004
Management of Influenza in Households:A Prospective,Randomized Comparison of Oseltimivir Treatment With or Without Postexposure Prophylaxis.Adis International Ltd,May ...
Hayden FG, Belche R, Villanueva C, ADIS International LTD, 5/15/2003
The Efficacy and Tolerability of Moxifloxacin Compared to Trovafloxacin in the Treatment of Acute Sinusitis.Today's Therapeutic Trends17(4):303-319,1999
Baz MN, Jannetti W , Villanueva C, Today’s Therapeutic Trends, 10/15/1999
Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
Burke, Villanueva, Mariano, Clinical Therapeutics, 10/1/1999
Join now to see all

Abstracts/Posters

Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
Burke T, Villanueva C, Clinical Therapeutics, 10/15/1999